237 related articles for article (PubMed ID: 18199711)
21. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.
Espinosa E; Vara JA; Redondo A; Sánchez JJ; Hardisson D; Zamora P; Pastrana FG; Cejas P; Martínez B; Suárez A; Calero F; Barón MG
J Clin Oncol; 2005 Oct; 23(29):7278-85. PubMed ID: 16129846
[TBL] [Abstract][Full Text] [Related]
23. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
Weigelt B; Kreike B; Reis-Filho JS
Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
[TBL] [Abstract][Full Text] [Related]
24. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
25. Lineage infidelity and expression of melanocytic markers in human breast cancer.
Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
[TBL] [Abstract][Full Text] [Related]
27. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
[TBL] [Abstract][Full Text] [Related]
28. A SAGE (serial analysis of gene expression) view of breast tumor progression.
Porter DA; Krop IE; Nasser S; Sgroi D; Kaelin CM; Marks JR; Riggins G; Polyak K
Cancer Res; 2001 Aug; 61(15):5697-702. PubMed ID: 11479200
[TBL] [Abstract][Full Text] [Related]
29. Architectural pattern of the normal and cancerous breast under the influence of parity.
Russo J; Romero AL; Russo IH
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):219-24. PubMed ID: 8019370
[TBL] [Abstract][Full Text] [Related]
30. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
[TBL] [Abstract][Full Text] [Related]
31. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.
Blakely CM; Stoddard AJ; Belka GK; Dugan KD; Notarfrancesco KL; Moody SE; D'Cruz CM; Chodosh LA
Cancer Res; 2006 Jun; 66(12):6421-31. PubMed ID: 16778221
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiles of the fibroblasts from breast tumors and normal tissue compared with the tumor expression profiles.
Hussain SS; Qattan AT; Nirmal MS; Al-Malik OA; Al-Tweigeri TA; Tulba AM; Bin Amer SM
Saudi Med J; 2006 Apr; 27(4):463-9. PubMed ID: 16598321
[TBL] [Abstract][Full Text] [Related]
33. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
34. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
35. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
37. Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
Folgueira MA; Carraro DM; Brentani H; Patrão DF; Barbosa EM; Netto MM; Caldeira JR; Katayama ML; Soares FA; Oliveira CT; Reis LF; Kaiano JH; Camargo LP; Vêncio RZ; Snitcovsky IM; Makdissi FB; e Silva PJ; Góes JC; Brentani MM
Clin Cancer Res; 2005 Oct; 11(20):7434-43. PubMed ID: 16243817
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
